Consequently, since the enzymatic catalytic site may have one or more pockets for substrate binding, and may generally be suitable for drug design and development (i.e., druggable), the rhamnosylation enzyme EarP(Nm) is an attractive target for antibiotic drug development toward the treatment of meningitis.
Source: wiktionary